Drugs that contain Isavuconazonium Sulfate
1. Drug name - CRESEMBA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US6812238 | ASTELLAS | N-substituted carbamoyloxyalkyl-azolium derivatives |
Oct, 2025
(3 years from now) | |
| CN1185230C | ASTELLAS | N-Substituted Carbamoyl Oxy Alkyl-Pyrrole Derivatives |
Oct, 2020
(1 year, 11 months ago) | |
| CN1387529A | ASTELLAS | N-Substituted Carbamoyl Oxy Alkyl-Pyrrole Derivatives |
Oct, 2020
(1 year, 11 months ago) | |
| EP1280795A2 | ASTELLAS | N-Substituted Carbamoyloxyalkyl-Azolium Derivatives |
Oct, 2020
(1 year, 11 months ago) | |
| EP1280795B1 | ASTELLAS | N-Substituted Carbamoyloxyalkyl-Azolium Derivatives |
Oct, 2020
(1 year, 11 months ago) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10206879 | ASTELLAS | Active ingredient containing stabilised solid forms and method for the production thereof |
Sep, 2027
(4 years from now) | |
| US10603280 | ASTELLAS | Active ingredient containing stabilised solid medicinal forms and methods for the production thereof |
Sep, 2027
(4 years from now) | |
Treatment: NA
Dosage: POWDER;INTRAVENOUS
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 372MG | POWDER;INTRAVENOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.